Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

June 27, 2014

Primary Completion Date

February 21, 2016

Study Completion Date

March 16, 2016

Conditions
Dysmenorrhea
Interventions
DRUG

Meloxicam

1 Meloxicam Vaginal Ring (MVR) for 4-6 days

DRUG

Diclofenac Potassium

1 tablet 50 mg diclofenac every 12 hours for 4-6 days

DRUG

Placebo Oral

1 placebo tablet every 12 hours for 4-6 days

DRUG

Placebo Vaginal

1 placebo vaginal ring for 4-6 days

Trial Locations (1)

8320165

Instituto Chileno de Medicina Reproductiva (ICMER), Santiago

Sponsors
All Listed Sponsors
lead

Laboratorios Andromaco S.A.

INDUSTRY

NCT02255045 - Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea | Biotech Hunter | Biotech Hunter